Boston, MA 03\/21\/2014 (wallstreetpr) – Sorrento Therapeutics Inc (NASDAQ:SRNE)<\/b> continues to strike the right cord with investors. Shares of the company have maintained their uptrend without showing any signs of fatigue. The uptrend gained energy following the announcement that industry veteran Mark Durand was joining the company\u2019s board of directors. The management described Durand as dedicated and high-energy executive who comes to Sorrento with a vast wealth of experience in matters pharmaceutical business. Thus, the company stated that his vast experience in development and commercialization of therapeutic drugs should help Sorrento identify more opportunities for growth. Shares of the company closed at $15.91, up 9.72 percent during Thursday session. The high volume session saw shares experiencing intraday range of $14.31 – $15.98. The stock opened the previous session at $14.55.<\/p>\n
Zuoan Fashion Ltd (ADR) (NYSE:ZA)<\/b> is a provider of men\u2019s casual wear. The company has dominant presence in China in terms of operation locations. It has footprint in 31 out of the 32 provinces of China. Its products are primarily in-house designed casual apparel for men, footwear as well as lifestyle accessories. Its customer targets are men in the age bracket of 20 to 40. The exciting atmosphere that is seen among apparel stocks has also caught up with ZA. Shares of the company opened the previous session at $2.07, but ended the day at $2.28, up 9.62 percent from the day ago closing price. The gain in the stock came on no particular company news, but generally on the positive prospects that analysts have predicted for apparel companies from the U.S. to China to other parts of the world.<\/p>\n
Open Text Corporation (USA) (NASDAQ:OTEX)<\/b> is a provider of information management solutions targeted at companies to help with content management and organization. Through its software technology, companies can easily collaborate with partners and address the regulatory requirements efficiently and almost seamlessly. The company currently has more than nine data facilities in Europe and the U.S. and it is planning to invest more than $40 million it set up data facilities in Australia over the next three years. According to the company\u2019s chief technology officer Patrick Harper, they have immediate plan to invest $1 million in Australia.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 03\/21\/2014 (wallstreetpr) – Sorrento Therapeutics Inc (NASDAQ:SRNE) continues to strike the right cord with investors. Shares of the company have maintained their uptrend […]<\/p>\n","protected":false},"author":6,"featured_media":17769,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[5390,5388,4951,5389,5387,4950],"stock_ticker":[],"class_list":["post-17767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-nasdaqotex","tag-nasdaqsrne","tag-nyseza","tag-open-text-corporation-usa-nasdaqotex","tag-sorrento-therapeutics-inc-nasdaqsrne","tag-zuoan-fashion-ltd-adr-nyseza","entry"],"acf":[],"yoast_head":"\n